CHAPTER 1 INTRODUCTION

1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models

CHAPTER 2 EXECUTIVE SUMMARY

2.1. CXO PERSPECTIVE

CHAPTER 3 MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS

3.2.1. Top investment pockets
3.2.2. Top winning strategies

3.3. PORTERS FIVE FORCES ANALYSIS
3.4. GOVERNMENT REGULATIONS
3.5. MARKET DYNAMICS

3.5.1. Drivers

3.5.1.1. Rise in number of needle-stick injuries
3.5.1.2. Increase in consumption of injectable drugs and vaccines
3.5.1.3. Active Government initiatives
3.5.1.1. Surge in application of injection and infusion therapies

3.5.2. Restraints

3.5.2.1. High cost of safety hypodermic needles
3.5.2.2. Alternative modes of drug delivery
3.5.2.3. Limited awareness of hypodermic needles in emerging economies

3.5.3. Opportunities

3.5.3.1. High prevalence of blood borne diseases
3.5.3.2. Lucrative opportunities in emerging economies

CHAPTER 4 HYPODERMIC NEEDLES MARKET, BY PRODUCT TYPE

4.1. OVERVIEW

4.1.1. Market size and forecast

4.2. SAFETY HYPODERMIC NEEDLES

4.2.1. Key market trends
4.2.2. Growth factors and opportunities
4.2.3. Market size and forecast
4.2.4. Safety Hypodermic needles, by type

4.2.4.1. Market size and forecast
4.2.4.2. Retractable safety hypodermic needles

4.2.4.2.1. Market size and forecast

4.2.4.3. Non-retractable safety hypodermic needles

4.2.4.3.1. Market size and forecast

4.2.5. Safety Hypodermic needles, by Mode of Activation

4.2.5.1. Market size and forecast
4.2.5.2. Active Safety Hypodermic Needles

4.2.5.2.1. Market size and Forecast

4.2.5.3. Passive Safety Hypodermic Needles

4.2.5.3.1. Market size and Forecast

4.3. NON-SAFETY HYPODERMIC NEEDLES

4.3.1. Key market trends
4.3.2. Growth factors and opportunities
4.3.3. Market size and forecast

CHAPTER 5 HYPODERMIC NEEDLES MARKET, BY APPLICATION

5.1. OVERVIEW

5.1.1. Market size and forecast

5.2. DRUG DELIVERY

5.2.1. Market size and forecast

5.3. VACCINATION

5.3.1. Market size and forecast

5.4. BLOOD SPECIMEN COLLECTION

5.4.1. Market size and forecast

CHAPTER 6 HYPODERMIC NEEDLES MARKET, BY END USER

6.1. OVERVIEW

6.1.1. Market size and forecast

6.2. HOSPITALS

6.2.1. Market size and forecast

6.3. DIABETIC PATIENTS

6.3.1. Market size and forecast

6.4. FAMILY PRACTICES

6.4.1. Market size and forecast

6.5. PSYCHIATRICS

6.5.1. Market size and Forecast

6.6. OTHERS

6.6.1. Market size and forecast

CHAPTER 7 HYPODERMIC NEEDLES MARKET, BY GEOGRAPHY

7.1. OVERVIEW

7.1.1. Market size and forecast

7.2. NORTH AMERICA

7.2.1. Key market trends
7.2.2. Key growth factors and opportunities
7.2.3. Market size and forecast

7.2.3.1. U.S. market size and forecast
7.2.3.2. Canada market size and forecast
7.2.3.3. Mexico market size and forecast

7.3. EUROPE

7.3.1. Key market trends
7.3.2. Key growth factors and opportunities
7.3.3. Market size and forecast

7.3.3.1. Germany market size and forecast
7.3.3.2. France market size and forecast
7.3.3.3. UK market size and forecast
7.3.3.4. Italy market size and forecast
7.3.3.5. Spain market size and forecast
7.3.3.6. Russia market size and forecast
7.3.3.7. Rest of Europe market size and forecast

7.4. ASIA-PACIFIC

7.4.1. Key market trends
7.4.2. Key growth factors and opportunities
7.4.3. Market size and forecast

7.4.3.1. Japan market size and forecast
7.4.3.2. China market size and forecast
7.4.3.3. Australia market size and forecast
7.4.3.4. India market size and forecast
7.4.3.5. South Korea market size and forecast
7.4.3.6. Taiwan market size and forecast
7.4.3.7. Indonesia market size and forecast
7.4.3.8. Thailand market size and forecast
7.4.3.9. Rest of Asia-Pacific market size and forecast

7.5. LAMEA

7.5.1. Key market trends
7.5.2. Key growth factors and opportunities
7.5.3. Market size and forecast

7.5.3.1. Brazil market size and forecast
7.5.3.2. Turkey market size and forecast
7.5.3.3. Venezuela market size and forecast
7.5.3.4. Saudi Arabia market size and forecast
7.5.3.5. South Africa market size and forecast
7.5.3.6. Colombia market size and forecast
7.5.3.7. Argentina market size and forecast
7.5.3.8. Rest of LAMEA market size and forecast

CHAPTER 8 COMPANY PROFILES

8.1. BECTON, DICKINSON AND COMPANY

8.1.1. Company overview
8.1.2. Operating business segments
8.1.3. Business performance
8.1.4. Key strategic moves & developments

8.2. B. BRAUN MELSUNGEN AG

8.2.1. Company overview
8.2.2. Operating business segments
8.2.3. Business performance
8.2.4. Key strategies and developments

8.3. CATALENT, INC.

8.3.1. Company overview
8.3.2. Operating business segments
8.3.3. Business performance

8.4. CONNECTICUT HYPODERMICS INC.

8.4.1. Company overview
8.4.2. Operating business segments
8.4.3. Business performance

8.5. EXELINT INTERNATIONAL CO.

8.5.1. Company overview
8.5.2. Operating business segments
8.5.3. Business performance

8.6. MEDPRO SAFETY PRODUCTS, INC.

8.6.1. Company overview
8.6.2. Operating business segments
8.6.3. Business performance

8.7. MEDTRONIC PLC

8.7.1. Company overview
8.7.2. Operating business segments
8.7.3. Business performance

8.8. RETRACTABLE TECHNOLOGIES, INC.

8.8.1. Company overview
8.8.2. Operating business segments
8.8.3. Business performance

8.9. SMITHS GROUP PLC

8.9.1. Company overview
8.9.2. Operating business segments
8.9.3. Business performance

8.10. TERUMO MEDICAL CORPORATION

8.10.1. Company overview
8.10.2. Business performance